Assessing the pharmacokinetic profile of the CamMedNP natural products database: an in silico approach
about
The potential of anti-malarial compounds derived from African medicinal plants, part II: a pharmacological evaluation of non-alkaloids and non-terpenoidsPharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plantsThe potential of anti-malarial compounds derived from African medicinal plants, part III: an in silico evaluation of drug metabolism and pharmacokinetics profiling.Antiparasitic Sesquiterpenes from the Cameroonian Spice Scleria striatinux and Preliminary In Vitro and In Silico DMPK Assessment.The potential of anti-malarial compounds derived from African medicinal plants, part I: a pharmacological evaluation of alkaloids and terpenoids.A bioactivity versus ethnobotanical survey of medicinal plants from Nigeria, west Africa.The chemistry and bioactivity of Southern African flora II: flavonoids, quinones and minor compound classesHow “drug-like” are naturally occurring anti-cancer compounds?The uniqueness and therapeutic value of natural products from West African medicinal plants, part II: terpenoids, geographical distribution and drug discoveryThe uniqueness and therapeutic value of natural products from West African medicinal plants. Part I: uniqueness and chemotaxonomyBinding of anti-Trypanosoma natural products from African flora against selected drug targets: a docking studyMolecular modeling of plant metabolites with anti-Onchocerca activityThe chemistry and bioactivity of Southern African flora I: a bioactivity versus ethnobotanical survey of alkaloid and terpenoid classesThe chemistry and biological activities of natural products from Northern African plant families: from Ebenaceae to SolanaceaeThe chemistry and biological activities of natural products from Northern African plant families: from Aloaceae to Cupressaceae
P2860
Q26824879-58365480-1811-4EB8-A5C9-267EDE73EAEBQ28596537-D29D7AA5-6BEC-4B07-B143-1DC96A3D0A7DQ30315979-5B09604C-A85E-49DC-8E33-9ECAC9B28513Q33825850-2AE82EA4-F793-4F54-A25B-43B34BFB0DA8Q37427043-D0214248-C79E-42A4-B459-FFB1AB85C7F4Q37642180-031A130B-A847-409B-BB6F-0708DA59290AQ58860050-95B0E460-0782-4633-8D36-5D8432F61BC3Q58860057-5115CA09-E5B6-4999-A76F-25FD8EFAC1CCQ58860062-4ED9312A-29F8-4F61-8452-2B981C6F02E3Q58860065-A6603E62-D14C-4ABA-A443-AE2B9A2A99A0Q58862088-C3EE70A0-BD3F-4E8F-9D78-439F941F8FA4Q58862097-E03AD0A0-FB96-4AB3-B7BE-09FC44785C0FQ58862099-ACC30746-0CC3-4EB2-B7DD-5B9E5DF5ADC9Q58862103-E7EF2AF4-11EE-42EC-A502-E33C57981FB2Q58862108-061F56E9-E336-4891-A704-54622BBC8C8B
P2860
Assessing the pharmacokinetic profile of the CamMedNP natural products database: an in silico approach
description
scientific article published on 30 August 2013
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2013
@uk
name
Assessing the pharmacokinetic ...... atabase: an in silico approach
@en
Assessing the pharmacokinetic ...... atabase: an in silico approach
@nl
type
label
Assessing the pharmacokinetic ...... atabase: an in silico approach
@en
Assessing the pharmacokinetic ...... atabase: an in silico approach
@nl
prefLabel
Assessing the pharmacokinetic ...... atabase: an in silico approach
@en
Assessing the pharmacokinetic ...... atabase: an in silico approach
@nl
P2093
P2860
P356
P1476
Assessing the pharmacokinetic ...... atabase: an in silico approach
@en
P2093
Eugene Megnassan
James A Mbah
Luc C Owono Owono
Luc Meva'a Mbaze
Lydia L Lifongo
Philip N Judson
Simon Mn Efange
Wolfgang Sippl
P2860
P356
10.1186/2191-2858-3-10
P407
P577
2013-08-30T00:00:00Z